- Media Highlights(13)
- News Mentions(7)
- Podcasts(6)
The rise of subscription-based AI platforms for drug discovery
2m read 10th April, 2024.
Making Undruggable Targets a Thing of the Past
0m read 4th April, 2024.
How biotech companies are using AI to design drugs
2m read 4th April, 2024.
This Biotech Founder Wants to Use AI to Help Get Drugs to Market Faster
7m read 21st March, 2024.
Microsoft and 1910 Genetics Partner to Build the Infrastructure Layer for Drug Discovery and Development Using AI and High-Performance Computing
6m read 29th February, 2024.
JP Morgan 2024 – Jen Nwankwo
0m read 29th January, 2024.
Touching Base: Alzheimer’s Disease, Monkey Cloning, Cytokinetics Stock; and Jen Nwankwo
0m read 22nd January, 2024.
Data’s hidden gems with Microsoft and Sam Altman-backed 1910 Genetics
0m read 17th January, 2024.
Biotech bounces back at JPM 2024 on optimism, breakthroughs and calculated bets, but uncertainties persist
1m read 17th January, 2024.
1910 Genetics Appoints Dr. Shaan C. Gandhi as Independent Board Director
2m read 19th December, 2023.
1910 Genetics Appoints Bridget Cole to Chief Scientific Officer
3m read 15th November, 2023.
Beyond OpenAI: Sam Altman The Investor Takes Center Stage
4m read 26th July, 2023.